section,entity_id,entity_name,entity_name_en,entity_type,category,attribute_path,value,evidence_source
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,name_en,Pediatric Growth Hormone Deficiency,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,description,儿童期生长激素分泌不足导致的生长发育迟缓,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,icd_10,E23.0,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.prevalence,1/4000-1/10000儿童,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.male_predominance,男性较女性多见(2-3:1),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.peak_diagnosis_age,5-15岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.ethnic_differences,各种族均可发病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.congenital.percentage,5-10%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.congenital.causes,下丘脑-垂体发育异常; 基因突变; 围产期损伤,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.acquired.percentage,5-10%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.acquired.causes,颅脑外伤; 颅内肿瘤; 感染; 放射治疗,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.idiopathic.percentage,80-90%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_etiology.idiopathic.characteristics,原因不明,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.complete_deficiency.gh_peak,<3ng/mL,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.complete_deficiency.growth_velocity,<4cm/年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.partial_deficiency.gh_peak,3-10ng/mL,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.partial_deficiency.growth_velocity,4-6cm/年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.gh_neurosecretory_dysfunction.gh_peak,正常,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,classification.by_severity.gh_neurosecretory_dysfunction.spontaneous_secretion,降低,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.gh_axis.hypothalamus,GHRH分泌,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.gh_axis.pituitary,GH分泌,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.gh_axis.liver,IGF-1产生,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.gh_axis.target_tissues,生长促进,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.growth_effects.linear_growth,骨骺软骨增殖,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.growth_effects.protein_synthesis,蛋白质合成增加,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.growth_effects.lipolysis,脂肪分解,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.growth_effects.glucose_metabolism,血糖调节,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.deficiency_consequences.growth_retardation,生长速度减慢,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.deficiency_consequences.body_composition,脂肪增加，肌肉减少,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.deficiency_consequences.bone_maturation,骨龄延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,pathophysiology.deficiency_consequences.metabolic_effects,低血糖倾向,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_parameters.short_stature,身高<第3百分位或<-2SD,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_parameters.growth_velocity,生长速度<第25百分位,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_parameters.height_sds,身高标准差分数持续下降,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_parameters.target_height,明显低于遗传靶身高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_features.proportionate_short_stature,匀称性矮小,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_features.immature_facial_features,面容幼稚,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_features.high_pitched_voice,声音尖细,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_features.delayed_dental_eruption,牙齿萌出延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.body_composition.increased_fat_mass,脂肪量增加,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.body_composition.decreased_muscle_mass,肌肉量减少,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.body_composition.central_adiposity,向心性肥胖,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.body_composition.thin_hair,毛发稀疏,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.metabolic_manifestations.hypoglycemia,低血糖(新生儿期),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.metabolic_manifestations.delayed_puberty,青春期延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.metabolic_manifestations.reduced_bone_density,骨密度降低,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.metabolic_manifestations.insulin_sensitivity,胰岛素敏感性增加,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.auxological_assessment.growth_charts,生长曲线评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.auxological_assessment.height_velocity,生长速度计算,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.auxological_assessment.bone_age,骨龄测定,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.auxological_assessment.body_proportions,坐高/身高比值,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igf1.normal_range,年龄性别特异性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igf1.screening_test,IGF-1水平,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igf1.limitations,营养状态影响,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igfbp3.complementary,IGF结合蛋白3,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igfbp3.stability,较IGF-1稳定,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.biochemical_tests.igfbp3.age_dependence,年龄相关变化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.indications,IGF-1低于正常; 生长速度<4cm/年; 临床高度怀疑,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.insulin_tolerance.stimulant,胰岛素0.1-0.15U/kg,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.insulin_tolerance.contraindications,癫痫、心脏病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.insulin_tolerance.gh_peak,正常>10ng/mL,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.arginine_stimulation.dose,精氨酸0.5g/kg,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.arginine_stimulation.safety,相对安全,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.arginine_stimulation.efficacy,中等刺激强度,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.clonidine_test.dose,可乐定4μg/kg,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.clonidine_test.side_effects,嗜睡、低血压,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.clonidine_test.convenience,口服给药,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.glucagon_test.dose,胰高血糖素15μg/kg,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.glucagon_test.advantages,禁食时间短,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.tests.glucagon_test.limitations,恶心呕吐,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.interpretation.normal_response,GH峰值>10ng/mL,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.interpretation.deficiency,两次试验均<10ng/mL,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.stimulation_tests.interpretation.partial_deficiency,一次正常一次异常,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.mri_pituitary.indications,确诊GH缺乏; 多重垂体激素缺乏; 神经系统症状,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.mri_pituitary.findings,垂体前叶缺如; 垂体柄中断; 异位后叶,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.method,左手腕X线,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.evaluation,Greulich-Pyle法,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.findings,骨龄明显延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.indications,确诊GH缺乏; 生长速度<4cm/年; 骨龄明显延迟; IGF-1持续低水平,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.preparations.recombinant_gh,重组人生长激素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.preparations.daily_injection,每日皮下注射,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.preparations.evening_administration,模拟生理节律,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.dosing.initial_dose,0.025-0.035mg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.dosing.adjustment,根据生长反应调整,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.dosing.maximum_dose,0.05mg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.dosing.frequency,每日1次,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.monitoring.growth_velocity,每3-6个月测量身高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.monitoring.igf1_levels,每6个月检测IGF-1,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.monitoring.side_effects,定期安全性评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.growth_hormone_therapy.monitoring.bone_age,每年评估骨龄进展,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.first_year.expected_growth,8-12cm/年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.first_year.catch_up_growth,追赶性生长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.first_year.igf1_normalization,IGF-1水平正常化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.subsequent_years.growth_velocity,6-8cm/年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.subsequent_years.height_sds_improvement,身高标准差改善,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.subsequent_years.pubertal_growth,青春期生长加速,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.poor_response.definitions,<4cm/年增长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.treatment_response.poor_response.causes,依从性差; 剂量不足; 其他疾病; 抗体产生,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.adjuvant_treatments.nutritional_support,确保充足营养,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.adjuvant_treatments.thyroid_hormone,甲状腺功能减退时,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.adjuvant_treatments.sex_hormones,青春期延迟时,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,treatment.adjuvant_treatments.psychological_support,心理社会支持,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.growth_parameters,身高、体重每3个月; 生长速度计算; 身高标准差变化; 青春期发育评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.laboratory_monitoring,IGF-1每6个月; 甲状腺功能每年; 糖化血红蛋白; 骨代谢标志物,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.safety_monitoring,局部反应; 抗体检测; 颅内压增高; 糖代谢异常; 甲状腺功能; 脊柱侧弯,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.imaging_follow_up,骨龄每年; 垂体MRI(如有指征); 脊柱X线(监测侧弯),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,complications.untreated_consequences,成人矮小症; 心理社会问题; 代谢异常; 骨质疏松; 心血管风险增加,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,complications.treatment_related,注射部位反应; 一过性颅内压增高; 糖耐量异常; 甲状腺功能减退; 脊柱侧弯进展,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.growth_outcomes.early_treatment,接近正常身高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.growth_outcomes.late_treatment,改善有限,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.growth_outcomes.final_height,取决于治疗时机和依从性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.quality_of_life,显著改善自信心和社会适应,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.long_term_benefits,改善体成分和代谢状态,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_001,儿童生长激素缺乏症,,endocrine_disorder,pediatric_endocrine_disease,prognosis.transition_to_adult,成年期继续治疗考虑,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,name_en,Pediatric Thyroid Disorders,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,description,儿童期甲状腺功能异常和结构性疾病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,icd_10,E03-E05,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.hypothyroidism_prevalence,先天性甲减1/2000-1/4000新生儿,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.hyperthyroidism_prevalence,"儿童甲亢1/100,000",Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.thyroid_nodules,儿童甲状腺结节1-5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.gender_distribution,女性多于男性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.primary.percentage,85%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.primary.causes,甲状腺发育不全; 甲状腺异位; 激素合成缺陷,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.central.percentage,5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.central.causes,TSH缺乏; TRH缺乏; 垂体下丘脑疾病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.transient.percentage,10%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.congenital_hypothyroidism.transient.causes,母体抗甲状腺药物; 碘过量或不足; 早产儿,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.autoimmune.hashimoto_thyroiditis,桥本甲状腺炎,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.autoimmune.peak_age,青春期,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.autoimmune.associations,其他自身免疫病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.iatrogenic.post_surgical,术后甲减,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.iatrogenic.radiation_induced,放射性甲减,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.acquired_hypothyroidism.iatrogenic.drug_induced,药物性甲减,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.hyperthyroidism.graves_disease.percentage,95%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.hyperthyroidism.graves_disease.peak_age,10-15岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.hyperthyroidism.graves_disease.characteristics,弥漫性甲状腺肿大,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.hyperthyroidism.toxic_nodules.percentage,<5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,classification.hyperthyroidism.toxic_nodules.types,单发; 多发,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.congenital_hypothyroidism.neonatal_signs,延长性黄疸; 喂养困难; 便秘; 嗜睡; 体温不稳; 哭声嘶哑,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.congenital_hypothyroidism.later_manifestations,生长发育迟缓; 智力发育障碍; 骨龄延迟; 牙齿萌出延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.acquired_hypothyroidism.growth_effects,生长速度减慢; 青春期延迟; 骨龄延迟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.acquired_hypothyroidism.metabolic_effects,体重增加; 疲劳乏力; 便秘; 皮肤干燥,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.acquired_hypothyroidism.neurological_effects,学习困难; 注意力不集中; 记忆力下降,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.hyperthyroidism.growth_acceleration,身高体重快速增长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.hyperthyroidism.behavioral_changes,多动不安; 注意力不集中; 情绪不稳; 学习成绩下降,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.hyperthyroidism.physical_signs,甲状腺肿大; 心动过速; 多汗; 手震颤; 眼征(少见),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.newborn_screening.timing,出生后3-5天,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.newborn_screening.method,TSH筛查,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.newborn_screening.cutoff,TSH>20mIU/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.newborn_screening.follow_up,异常结果及时复查,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.thyroid_function.tsh,促甲状腺激素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.thyroid_function.ft4,游离甲状腺素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.thyroid_function.ft3,游离三碘甲状腺原氨酸,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.thyroid_function.reference_ranges,年龄特异性正常值,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.antibodies.tpoab,甲状腺过氧化物酶抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.antibodies.tgab,甲状腺球蛋白抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.antibodies.trab,TSH受体抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.laboratory_tests.thyroglobulin,甲状腺球蛋白水平,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_scintigraphy.indication,先天性甲减病因,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_scintigraphy.isotopes,99mTc或123I,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_scintigraphy.findings,缺如; 异位; 正常,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_ultrasound.indication,甲状腺肿大或结节,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_ultrasound.parameters,大小、形态、血流,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,diagnosis.imaging.thyroid_ultrasound.guided_biopsy,结节性质鉴别,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.levothyroxine.newborn_dose,10-15μg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.levothyroxine.infant_dose,6-10μg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.levothyroxine.child_dose,4-6μg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.levothyroxine.adolescent_dose,2-3μg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.administration.timing,空腹服用,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.administration.preparation,液体或片剂,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.administration.compliance,确保依从性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.monitoring.frequency,治疗初期每2-4周,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.monitoring.target_tsh,正常范围下半部,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hypothyroidism_treatment.monitoring.target_ft4,正常范围上半部,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.methimazole.dose,0.2-0.5mg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.methimazole.advantages,每日1次，较少副作用,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.methimazole.first_line,儿童首选,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.propylthiouracil.indication,妊娠、甲状腺危象,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.propylthiouracil.hepatotoxicity,肝毒性风险,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.antithyroid_drugs.propylthiouracil.monitoring,肝功能监测,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.beta_blockers.propranolol,普萘洛尔,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.beta_blockers.indication,症状控制,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.beta_blockers.dose,1-2mg/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.definitive_treatment.radioiodine.age_limit,一般>20岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.definitive_treatment.radioiodine.considerations,生育能力影响,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.definitive_treatment.radioiodine.contraindications,妊娠、哺乳,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.definitive_treatment.surgery.indications,巨大甲状腺肿; 压迫症状; 怀疑恶性; 药物治疗失败,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,treatment.hyperthyroidism_treatment.definitive_treatment.surgery.risks,喉返神经损伤、甲旁减,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,monitoring.growth_development,身高体重每3个月; 头围(婴儿); 骨龄评估; 智力发育评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,monitoring.thyroid_function,TSH、FT4每3-6个月; 抗体滴度变化; 药物剂量调整,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,monitoring.complications_screening,心血管系统; 神经系统发育; 其他自身免疫病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.congenital_hypothyroidism.early_treatment,正常智力发育,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.congenital_hypothyroidism.delayed_treatment,不可逆智力障碍,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.congenital_hypothyroidism.lifelong_treatment,终身激素替代,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.acquired_hypothyroidism.growth_catch_up,治疗后追赶性生长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.acquired_hypothyroidism.reversible_effects,多数症状可逆,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.acquired_hypothyroidism.long_term_outlook,预后良好,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.hyperthyroidism.remission_rate,40-60%缓解率,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.hyperthyroidism.relapse_risk,停药后复发风险,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_002,儿童甲状腺疾病,,endocrine_disorder,pediatric_endocrine_disease,prognosis.hyperthyroidism.long_term_monitoring,需长期随访,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,name_en,Pediatric Type 1 Diabetes,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,description,儿童期胰岛β细胞自身免疫性破坏导致的绝对胰岛素缺乏,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,icd_10,E10,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,epidemiology.global_incidence,每年增加3-5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,epidemiology.china_incidence,0.6/10万儿童年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,epidemiology.peak_ages,5-7岁和10-14岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,epidemiology.gender_ratio,男女大致相等,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,epidemiology.ethnic_differences,白种人发病率最高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.autoimmune_destruction.target,胰岛β细胞,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.autoimmune_destruction.mechanism,T细胞介导的自身免疫,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.autoimmune_destruction.triggers,病毒感染; 环境因素; 遗传易感性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.autoimmune_destruction.progression,从正常→糖耐量异常→糖尿病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.genetic_susceptibility.hla_associations,HLA-DR3/DR4,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.genetic_susceptibility.high_risk_haplotypes,DQB1*0302/DQA1*0501,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.genetic_susceptibility.protective_alleles,DQB1*0602,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.genetic_susceptibility.non_hla_genes,INS、PTPN22、CTLA4,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,pathophysiology.environmental_factors,肠道病毒感染; 早期牛奶蛋白暴露; 维生素D缺乏; 过度卫生假说,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.classic_symptoms.polyuria,多尿,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.classic_symptoms.polydipsia,多饮,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.classic_symptoms.polyphagia,多食,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.classic_symptoms.weight_loss,体重下降,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.diabetic_ketoacidosis.percentage,25-40%首发DKA,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.diabetic_ketoacidosis.younger_children,更易发生DKA,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.diabetic_ketoacidosis.symptoms,恶心呕吐; 腹痛; 呼吸困难; 意识改变,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.gradual_onset.symptoms,症状逐渐加重,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.gradual_onset.duration,数周至数月,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.presentation_patterns.gradual_onset.misdiagnosis,常被误诊,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.physical_findings.dehydration,脱水征象,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.physical_findings.weight_loss,明显消瘦,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.physical_findings.kussmaul_breathing,Kussmaul呼吸,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,clinical_presentation.physical_findings.acetone_breath,烂苹果味呼气,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.diagnostic_criteria.symptoms_plus,典型症状+随机血糖≥11.1mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.diagnostic_criteria.fasting_glucose,空腹血糖≥7.0mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.diagnostic_criteria.ogtt_2h,OGTT 2小时血糖≥11.1mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.diagnostic_criteria.hba1c,糖化血红蛋白≥6.5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.autoantibodies.gad_antibodies,GAD抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.autoantibodies.ia2_antibodies,IA-2抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.autoantibodies.zinc_transporter8,ZnT8抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.autoantibodies.insulin_autoantibodies,胰岛素自身抗体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.autoantibodies.positive_rate,90%患者至少一种阳性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.c_peptide.stimulated_test,胰高血糖素刺激试验,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.c_peptide.interpretation,评估胰岛功能,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.c_peptide.prognosis,预测蜜月期长短,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,diagnosis.differential_diagnosis,2型糖尿病; MODY; 新生儿糖尿病; 继发性糖尿病; 应激性高血糖,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.fluid_resuscitation.initial,20ml/kg生理盐水,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.fluid_resuscitation.maintenance,根据脱水程度补液,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.fluid_resuscitation.rate,48小时内纠正脱水,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.insulin_therapy.route,持续静脉滴注,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.insulin_therapy.dose,0.1U/kg/h,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.insulin_therapy.adjustment,血糖下降3-5mmol/L/h,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.insulin_therapy.glucose_addition,血糖<14mmol/L时加葡萄糖,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.electrolyte_management.potassium,监测并补充钾离子,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.electrolyte_management.phosphate,必要时补磷,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.electrolyte_management.sodium,避免过快纠正,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.monitoring.blood_glucose,每1-2小时,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.monitoring.electrolytes,每4-6小时,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.monitoring.arterial_blood_gas,监测酸中毒纠正,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.diabetic_ketoacidosis.monitoring.neurological_status,防止脑水肿,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.cerebral_edema.incidence,0.5-1%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.cerebral_edema.risk_factors,年龄<5岁; 严重酸中毒; 高尿素氮; 低PCO2,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,acute_management.cerebral_edema.management,甘露醇、限制补液,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.multiple_daily_injections.long_acting,基础胰岛素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.multiple_daily_injections.rapid_acting,餐前胰岛素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.multiple_daily_injections.advantages,灵活性好,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.insulin_pump.continuous_infusion,持续皮下胰岛素输注,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.insulin_pump.age_requirement,通常>6岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.regimens.insulin_pump.benefits,更精确控制,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.insulin_types.rapid_acting,门冬、赖脯、谷赖胰岛素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.insulin_types.long_acting,甘精、地特米、德谷胰岛素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.insulin_types.intermediate,NPH胰岛素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.dosing.total_daily_dose,0.5-1.2U/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.dosing.honeymoon_period,0.2-0.5U/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.dosing.established_diabetes,0.7-1.0U/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.insulin_therapy.dosing.adolescence,1.0-1.5U/kg/日,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.glucose_monitoring.self_monitoring,每日4-8次血糖监测,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.glucose_monitoring.continuous_glucose_monitoring.real_time_cgm,实时血糖监测,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.glucose_monitoring.continuous_glucose_monitoring.flash_glucose,瞬感血糖监测,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.glucose_monitoring.continuous_glucose_monitoring.benefits,减少低血糖、改善控制,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.glucose_monitoring.ketone_monitoring,血糖>13mmol/L时检测,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.hba1c.general_target,<7.5%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.hba1c.individualized,根据年龄调整,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.hba1c.hypoglycemia_risk,平衡获益与风险,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.blood_glucose.preprandial,5.0-7.2mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.blood_glucose.postprandial,<10.0mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,chronic_management.target_goals.blood_glucose.bedtime,6.7-10.0mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.hypoglycemia.definition,血糖<3.9mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.hypoglycemia.severe,需他人协助,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.hypoglycemia.treatment,葡萄糖片、胰高血糖素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.hypoglycemia.prevention,血糖监测、饮食配合,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.hyperglycemia,血糖>13mmol/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.acute_complications.ketoacidosis,反复DKA,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.chronic_complications.microvascular,糖尿病肾病; 糖尿病视网膜病变; 糖尿病神经病变,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.chronic_complications.macrovascular,动脉粥样硬化; 冠心病风险增加,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.chronic_complications.screening_recommendations.nephropathy,病程5年后每年筛查,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.chronic_complications.screening_recommendations.retinopathy,病程3-5年后每年筛查,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,complications.chronic_complications.screening_recommendations.neuropathy,青春期后每年筛查,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,psychosocial_management.family_education,糖尿病知识; 胰岛素注射技术; 血糖监测; 低血糖处理; 饮食管理,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,psychosocial_management.school_management,学校人员培训; 紧急处理方案; 体育活动安全; 考试安排调整,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,psychosocial_management.psychological_support,诊断时心理危机干预; 青春期心理问题; 家庭关系调适; 同伴支持小组,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,prognosis.life_expectancy,接近正常人群,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,prognosis.quality_of_life,良好管理下正常生活,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,prognosis.complications_prevention,严格控制可预防并发症,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_003,儿童1型糖尿病,,autoimmune_disorder,pediatric_endocrine_disease,prognosis.technology_advancement,新技术不断改善预后,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,name_en,Precocious Puberty,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,description,儿童第二性征过早出现的内分泌疾病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,icd_10,E30.1,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.prevalence,女孩1/5000，男孩1/25000,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.gender_difference,女孩发病率是男孩的10倍,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.ethnic_variations,非裔美国人发病率较高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,epidemiology.secular_trends,发病年龄呈提前趋势,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,definition.girls,8岁前出现第二性征,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,definition.boys,9岁前出现第二性征,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,definition.criteria.breast_development,乳房发育Tanner II期,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,definition.criteria.pubic_hair,阴毛出现,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,definition.criteria.testicular_enlargement,睾丸体积≥4ml,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.central_precocious_puberty.mechanism,下丘脑-垂体-性腺轴激活,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.central_precocious_puberty.percentage,女孩90%，男孩40%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.central_precocious_puberty.gonadotropin_dependent,促性腺激素依赖性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.peripheral_precocious_puberty.mechanism,性腺或肾上腺激素分泌,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.peripheral_precocious_puberty.percentage,女孩10%，男孩60%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,classification.peripheral_precocious_puberty.gonadotropin_independent,促性腺激素非依赖性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.idiopathic.percentage,女孩95%，男孩50%,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.idiopathic.characteristics,原因不明,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.pathological.cns_tumors,颅咽管瘤; 垂体腺瘤; 下丘脑错构瘤,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.pathological.cns_trauma,颅脑外伤,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.pathological.infections,脑炎、脑膜炎,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.central_causes.pathological.radiation,颅脑放疗史,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.peripheral_causes.gonadal,卵巢囊肿/肿瘤; 睾丸肿瘤; McCune-Albright综合征,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.peripheral_causes.adrenal,先天性肾上腺皮质增生症; 肾上腺肿瘤; 库欣综合征,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,etiology.peripheral_causes.exogenous,外源性性激素暴露; 环境内分泌干扰物,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.girls.breast_development,乳房发育,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.girls.growth_spurt,身高快速增长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.girls.pubic_hair,阴毛出现,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.girls.menarche,月经初潮,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.girls.body_odor,体味出现,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.boys.testicular_enlargement,睾丸增大,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.boys.penile_growth,阴茎增长,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.boys.pubic_hair,阴毛出现,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.boys.voice_changes,声音变化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.physical_changes.boys.muscle_development,肌肉发育,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_patterns.accelerated_growth,生长速度加快,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_patterns.advanced_bone_age,骨龄超前,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_patterns.early_epiphyseal_fusion,骨骺过早闭合,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.growth_patterns.final_height_compromise,最终身高受损,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.psychological_effects.body_image_concerns,身体形象焦虑,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.psychological_effects.peer_relationship_issues,同伴关系问题,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.psychological_effects.premature_sexualization,过早性化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,clinical_manifestations.psychological_effects.emotional_immaturity,情感不成熟,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.clinical_assessment.tanner_staging,Tanner分期评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.clinical_assessment.growth_velocity,生长速度计算,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.clinical_assessment.family_history,家族青春期发育史,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.clinical_assessment.medication_history,药物和暴露史,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.basal_hormones.lh,黄体生成素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.basal_hormones.fsh,卵泡刺激素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.basal_hormones.estradiol,雌二醇(女孩),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.basal_hormones.testosterone,睾酮(男孩),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.gnrh_stimulation_test.indication,鉴别中枢性vs外周性,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.gnrh_stimulation_test.method,GnRH 100μg静脉注射,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.gnrh_stimulation_test.interpretation.central,LH峰值>5IU/L,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.gnrh_stimulation_test.interpretation.peripheral,LH反应不明显,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.additional_tests.thyroid_function,甲状腺功能,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.additional_tests.adrenal_function,肾上腺皮质功能,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.laboratory_tests.additional_tests.tumor_markers,肿瘤标志物,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.method,左手腕X线,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.finding,骨龄超前>2年,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.bone_age.prognosis,预测最终身高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.brain_mri.indication,男孩或女孩<6岁,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.brain_mri.findings,排除颅内病变,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.brain_mri.sequences,包括垂体薄层扫描,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.pelvic_ultrasound.girls,卵巢、子宫发育评估,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.pelvic_ultrasound.findings,器官大小和形态,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.testicular_ultrasound.boys,睾丸大小和结构,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,diagnostic_evaluation.imaging_studies.testicular_ultrasound.indication,排除肿瘤,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.mechanism,下调GnRH受体,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.preparations.leuprolide,亮丙瑞林 3.75mg/月,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.preparations.triptorelin,曲普瑞林 3.75mg/月,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.preparations.goserelin,戈舍瑞林 3.6mg/月,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.administration,肌内注射,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.gnrh_agonists.duration,直到适当年龄,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.monitoring.clinical_response,第二性征进展停止,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.monitoring.hormonal_suppression,性激素降至青春期前水平,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.monitoring.growth_velocity,生长速度恢复正常,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.central_precocious_puberty.monitoring.side_effects,骨密度、情绪变化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.peripheral_precocious_puberty.treat_underlying_cause,治疗原发疾病,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.peripheral_precocious_puberty.specific_therapies.mccune_albright,芳香化酶抑制剂,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.peripheral_precocious_puberty.specific_therapies.adrenal_disorders,糖皮质激素,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.peripheral_precocious_puberty.specific_therapies.tumors,手术切除,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.supportive_care.growth_hormone,联合GH治疗(特殊情况),Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.supportive_care.psychological_support,心理辅导,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,treatment.supportive_care.family_counseling,家庭支持,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.treatment_response,第二性征进展; 生长速度; 骨龄进展; 激素水平,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.side_effects_monitoring,骨密度(DXA); 情绪行为变化; 注射部位反应; 体重变化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,monitoring_and_follow_up.long_term_outcomes,最终身高; 生育能力; 心理社会适应; 骨健康,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.height_outcomes.treated,接近遗传潜能身高,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.height_outcomes.untreated,成人矮小,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.height_outcomes.treatment_timing,早期治疗效果更好,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.reproductive_health.fertility,正常生育能力,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.reproductive_health.menstrual_function,规律月经周期,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.reproductive_health.pregnancy_outcomes,正常妊娠结局,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.psychological_adjustment.self_esteem,自尊心改善,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.psychological_adjustment.peer_relationships,同伴关系正常化,Endocrine Society Clinical Practice Guidelines
pediatric_endocrine_entities,PED_004,儿童性早熟,,endocrine_disorder,pediatric_endocrine_disease,prognosis.psychological_adjustment.academic_performance,学业表现稳定,Endocrine Society Clinical Practice Guidelines
